EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating the structure-based virtual screening performance of SARS-CoV-2 main protease: A benchmarking approach and a multistage screening example against the wild-type and Omicron variants

Noha Galal, Botros Y Beshay, Omar Soliman, Muhammad I Ismail, Mohamed Abdelfadil, Mohamed El-Hadidi, Reem K Arafa, Tamer M Ibrahim iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0318712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Noha Galal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Drug Design and Discovery Laboratory, Zewail City of Science and Technology, October Gardens, 6th of October City, Giza, Egypt. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus 3C Proteases, Antiviral Agents, Protease Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 still poses a worldwide health threat due to continuous viral mutations and potential resistance to vaccination. SARS-CoV-2 viral multiplication hindrance by inhibiting the viral main protease (Mpro) deemed propitious. Structure-based virtual screening (SBVS) is a conventional strategy for discovering new inhibitors. Nonetheless, the SBVS efforts against Mpro variants needed to be benchmarked. Herein, in the first stage of the study, we evaluated four docking tools (FRED, PLANTS, AutoDock Vina and CDOCKER) via an in-depth benchmarking approach against SARS-CoV2 Mpro of both the wild type (WTMpro) and the deadly Omicron P132H variant (OMpro). We started by compiling an active dataset of non-covalent small molecule inhibitors of the WTMpro from literature and the COVID-Moonshot database along with generating a high-quality benchmark set via DEKOIS 2.0. pROC-Chemotype plots revealed superior performance for AutoDock Vina against WTMpro, while both FRED and AutoDock Vina demonstrated excellent performance for OMPro. In the second stage, VS was performed on a focused library of 636 compounds transformed from the early-enriched cluster related to perampanel via a scaffold hopping approach. Subsequently, molecular dynamics (MD) simulation and MM GBSA calculations validated the binding potential of the recommended hits against both explored targets. This study provides an example of how to conduct an in-depth benchmarking approach for both WTMPro and OMPro variants and offering an evaluated SBVS protocol for them both.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Coronavirus 3C ProteasesAntiviral AgentsProtease InhibitorsMolecular Docking SimulationHumansBenchmarkingCOVID-19Molecular Dynamics SimulationCOVID-19 Drug TreatmentDrug Evaluation, Preclinical

Substanzen

Coronavirus 3C ProteasesAntiviral AgentsProtease Inhibitors

Autor:innen und Institutionen

  • Drug Design and Discovery Laboratory, Zewail City of Science and Technology, October Gardens, 6th of October City, Giza, Egypt.
  • Biomedical Sciences Program, UST, Zewail City of Science and Technology, October Gardens, 6th of October City, Giza, Egypt.
  • Pharmaceutical Chemistry Department (Pharmaceutical Sciences Division), College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport, Alexandria, Egypt.
  • Genomics Program, Children's Cancer Hospital Egypt, Cairo, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.

ORCID-Profile: Tamer M Ibrahim

Zitieren

APA

Galal, N., Beshay, B. Y., Soliman, O., Ismail, M. I., Abdelfadil, M., El-Hadidi, M., Arafa, R. K., & Ibrahim, T. M. (2025). Evaluating the structure-based virtual screening performance of SARS-CoV-2 main protease: A benchmarking approach and a multistage screening example against the wild-type and Omicron variants. PLOS ONE. https://doi.org/10.1371/journal.pone.0318712

Vancouver

Galal N, Beshay BY, Soliman O, Ismail MI, Abdelfadil M, El-Hadidi M, et al. Evaluating the structure-based virtual screening performance of SARS-CoV-2 main protease: A benchmarking approach and a multistage screening example against the wild-type and Omicron variants. PLOS ONE. 2025. doi:10.1371/journal.pone.0318712

BibTeX
@article{Galal2025,
  author = {Galal, Noha and Beshay, Botros Y and Soliman, Omar and Ismail, Muhammad I and Abdelfadil, Mohamed and El-Hadidi, Mohamed and Arafa, Reem K and Ibrahim, Tamer M},
  title = {Evaluating the structure-based virtual screening performance of SARS-CoV-2 main protease: A benchmarking approach and a multistage screening example against the wild-type and Omicron variants},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0318712}
}
Kostenlos starten →